Yves Briers

Prof. dr. ir. Yves Briers has a PhD in Bioscience Engineering (2008) and is a leading expert in the field of phage lysins. In 2023 he co-founded Obulytix, a biotechnology platform company for the development of phage lysins as a novel class of enzyme-based antibiotics, for which he is appointed as CEO. He has been pioneering phage lysin research in an academic context (KU Leuven, ETH Zurich, Ghent University) since 2004 with a focus on phage lysins acting against Gram-negative pathogens and the development of tools to engineer, screen and characterize the antibacterial and preclinical properties of phage lysins as powerful antibacterials.